We could not really be happier to be working with a pioneer and market leader in such an important component of our overall business. Dealing with the team at AcuClaims will not only facilitate Insurance Verification and Billing Solutions however they will also help with creating value added relationships with crucial Insurance Carriers. Between our partnership with ARC to launch a new Marketing Campaign which we are specific will allow us to attain the patient flow goals we have and this fresh partnership with a innovator in Acupuncture and Complimentary Medicine Billing we are one step closer to becoming the first choice in the multiple specialties we are focusing on.All the authors presume responsibility for the overall integrity and articles of the article. Study Patients The inclusion criteria previously have already been described.4 Patients between the age groups of 35 and 85 years who experienced idiopathic pulmonary fibrosis had been permitted participate in the analysis if indeed they had mild-to-average impairment in pulmonary function, that was defined as a forced vital capability of 50 percent or more of the predicted value and a carbon monoxide diffusing capacity of 30 percent or even more of the predicted value. All patients were necessary to meet the modified requirements of the American Thoracic Culture, European Respiratory Culture, Japanese Respiratory Culture, and Latin American Thoracic Association for a analysis of idiopathic pulmonary fibrosis,1,5 which was determined on the basis of high-quality computed tomography or biopsy.